(Q34416654)

2 August 2017

Pharmacokinetics of intravenous and oral sodium 2-mercaptoethane sulphonate (mesna) in normal subjects (English)

1 reference

2 August 2017

1 reference

1 reference

James CA

1

1 reference

2 August 2017

Mant TG

series ordinal

2

1 reference

2 August 2017

Rogers HJ

series ordinal

3

1 reference

2 August 2017

language of work or name

English

0 references

publication date

1 May 1987

1 reference

British Journal of Clinical Pharmacology

2 August 2017

1 reference

2 August 2017

23

1 reference

2 August 2017

561-568

1 reference

2 August 2017

5

1 reference

2 August 2017

Tissue sulfhydryl groups

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1386192

Studies on the urotoxicity of oxazaphosphorine cytostatics and its prevention--I. Experimental studies on the urotoxicity of alkylating compounds

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1386192

2-Mercaptoethanesulfonate-cysteine disulfide excretion following the administration of 2-mercaptoethanesulfonate--a pitfall in the diagnosis of sulfite oxidase deficiency

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1386192

Pharmacokinetics and mechanism of action of detoxifying low-molecular-weight thiols

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1386192

Unexpected toxicity in patients treated with iphosphamide

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1386192

Simultaneous determination of 2-mercaptoethanesulfonate and its disulfide in human urine by isotachophoresis

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1386192

Acrolein, the causative factor of urotoxic side-effects of cyclophosphamide, ifosfamide, trofosfamide and sufosfamide

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1386192

Controlled clinical studies with an antidote against the urotoxicity of oxazaphosphorines: preliminary results

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1386192

Studies on the urotoxicity of oxazaphosphorine cytostatics and its prevention. 2. Comparative study on the uroprotective efficacy of thiols and other sulfur compounds

6 July 2018

1 reference

12 December 2020

Studies on the urotoxicity of oxazaphosphorine cytostatics and its prevention--III. Profile of action of sodium 2-mercaptoethane sulfonate (mesna)

1 reference

12 December 2020

High-dose ifosfamide by infusion with mesna in advanced soft tissue sarcoma

1 reference

12 December 2020

Clinical overview of mesna

1 reference

12 December 2020

Bioavailability of orally administered mesna

1 reference

12 December 2020

Excretion of sodium 2-mercaptoethanesulphonate (MESNA) in the urine of volunteers after oral dosing

1 reference

12 December 2020

Estimation of mesna and dimesna in plasma and urine by high-performance liquid chromatography with electrochemical detection

1 reference

12 December 2020

Biochemical, metabolic and pharmacological studies on a mucolytic: Mistabron

1 reference

12 December 2020

10.1111/J.1365-2125.1987.TB03092.X

Identifiers

DOI

1 reference

2 August 2017

1 reference

2 August 2017

1 reference